Anders Österborg

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

Michael Pfreundschuh, Evelyn Kuhnt, Lorenz Trümper et al. · The Lancet Oncology · 2011 · 811 citations

Medicine, Oncology, Pharmacotherapy +13

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

Francesco d’Amore, Thomas Relander, Grete F. Lauritzsen et al. · Journal of Clinical Oncology · 2012 · 590 citations

Medicine, Oncology, Cell Therapy +12

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia.

Anders Österborg, Martin J.S. Dyer, Donald Bunjes et al. · Journal of Clinical Oncology · 1997 · 518 citations

Medicine, Oncology, Pharmacology +16

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin et al. · Blood · 1998 · 306 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Matti Aapro, Yves Béguin, Carsten Bokemeyer et al. · Annals of Oncology · 2017 · 277 citations · Full text

Medicine, Hematology, Oncology +17